Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
33m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
1h agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Cabaletta Bio Inc logo

Cabaletta Bio Inc

About

Cabaletta Bio Inc (NASDAQ:CABA) — investor relations, events, news, and company updates on 6ix.

Latest News

Yesterday
Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel
Yesterday
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
Apr 27 2026
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
Apr 14 2026
First Patients Dosed with Cabaletta Bio’s Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform
Mar 23 2026
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Financials

Revenue
$0
Market Cap
$335.08 M
EPS
-2.10

Community Chat

Ask AI

6ix6ixAIEvents